Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

ASTH US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Astrana Health, Inc.(ASTH US)

$31.80+0.030.09%Ext:$22.90-8.9027.98%(Market Closed · 00:56:52 UTC)
Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

ASTH US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Astrana Health, Inc.(ASTH US)

$31.80+0.030.09%Ext:$22.90-8.9027.98%(Market Closed · 00:56:52 UTC)
Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees

Financials & Metrics

FinancialsChartingShort InterestEmployees

Astrana Health, Inc. — Company Profile

Astrana Health, Inc., which rebranded from Apollo Medical Holdings, Inc. in February 2024, is a healthcare management firm based in Alhambra, California, founded in 1985. This company delivers medical services throughout the United States, operating with a physician-centered approach powered by advanced technology. Its operations are structured across three distinct divisions: Care Partners, Care Delivery, and Care Enablement. Astrana Health utilizes its exclusive platform for population health management and healthcare delivery to implement an integrated, value-based care model. This strategic approach empowers the healthcare providers within its network to offer high-quality care to their patients. The organization provides extensive care coordination services to a broad spectrum of stakeholders, including patients, their families, primary care physicians, specialists, acute care hospitals, other inpatient facilities, physician groups, and health plans. Its robust physician network encompasses primary care doctors, specialized practitioners, advanced practice providers (extenders), and hospital-based physicians. Astrana Health serves a diverse patient base, primarily those with insurance coverage—such as private plans, Medicare, Medicaid, and HMOs—but also extends care to uninsured individuals.

Sector
Communication Services
Industry
Media
Exchange
UQ
CEO
Brandon K. Sim
Headquarters
Alhambra, CA, US
IPO Date
Mar 11, 2009
Employees
3,000
Website
www.astranahealth.com

Key Metrics

Price
$35.88
Market Cap
$1.78B
Revenue (TTM)
$965.10M
Net Income (TTM)
$14.44M
EPS (TTM)
0.30
P/E (TTM)
58.85
P/B (TTM)
2.22
Dividend Yield
0.00%
ROE (TTM)
1.80%
ROA (TTM)
0.61%
Operating Margin
2.96%
Beta
0.84

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

Astrana Health, Inc., which rebranded from Apollo Medical Holdings, Inc. in February 2024, is a healthcare management firm based in Alhambra, California, founded in 1985. This company delivers medical services throughout the United States, operating with a physician-centered approach powered by advanced technology. Its operations are structured across three distinct divisions: Care Partners, Care Delivery, and Care Enablement. Astrana Health utilizes its exclusive platform for population health management and healthcare delivery to implement an integrated, value-based care model. This strategic approach empowers the healthcare providers within its network to offer high-quality care to their patients. The organization provides extensive care coordination services to a broad spectrum of stakeholders, including patients, their families, primary care physicians, specialists, acute care hospitals, other inpatient facilities, physician groups, and health plans. Its robust physician network encompasses primary care doctors, specialized practitioners, advanced practice providers (extenders), and hospital-based physicians. Astrana Health serves a diverse patient base, primarily those with insurance coverage—such as private plans, Medicare, Medicaid, and HMOs—but also extends care to uninsured individuals.

Website
www.astranahealth.com
Location
Alhambra, CA, US
Phone626 282 0288
Employees3,000
CEOBrandon K. Sim
Sector
Communication Services
Industry
Media
IPO DateMar 11, 2009

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.
How it makes money
A short diagram of the business model.

Latest Documents

SEC Filings(1K)

Expand
  • 10-QQ3ended 30 Sept 20266 Nov
  • 8-KResults of Operations and Financial Condition5 Nov
  • SC 13G/AAstrana Health, Inc.30 Oct
  • Form 4Vong John13 Oct
  • Form 4Sim Brandon8 Oct
  • Form 4Lam Thomas S.8 Oct
  • Form 4Basho Chandan6 Oct
  • 8-KRegulation FD Disclosure23 Sep
  • 8-K<ITEMS>1.0523 Sep
  • Form 4Vong John17 Sep
  • 8-KRegulation FD Disclosure15 Sep
  • Form 4Sim Brandon9 Sep
  • Form 4Basho Chandan8 Sep
  • Form 4Kitayama Mitchell W1 Sep
  • Form 4Schmidt David18 Aug
  • Form 3Vong John11 Aug
  • Form 4Sobotka Glenn11 Aug
  • 10-QQ2ended 30 Jun 202610 Aug
  • 8-KResults of Operations and Financial Condition6 Aug
  • SC 13GAstrana Health, Inc.31 Jul

News

  • Foothill Regional Medical Center Recognized Among Healthgrades' 2027 America's 100 Best Hospitals for Orthopedic Surgery and Joint Replacement10 Nov
  • Astrana Health, Inc. (ASTH) Q3 2026 Earnings Call Transcript6 Nov
  • Astrana Health Q3 Earnings Call Highlights5 Nov
  • Astrana Health, Inc. (ASTH) Q3 Earnings Lag Estimates5 Nov
  • Astrana Health, Inc. Reports Third Quarter 2026 Results5 Nov
  • Diamond Hill Small Cap Fund Q3 2026 Portfolio Activity28 Oct
  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH22 Oct
  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH20 Oct
  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH15 Oct
  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH13 Oct
  • Is It Too Late to Buy Astrana Health Inc (ASTH) After 4.7% Rally? GF Value Says Undervalued9 Oct
  • Astrana Health, Inc. Schedules 2026 Third Quarter Financial Results Release and Conference Call9 Oct
  • Why Astrana Health, Inc. (ASTH) is Poised to Beat Earnings Estimates Again9 Oct
  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH8 Oct
  • Astrana Health, Inc. (NASDAQ:ASTH) Stock Rated “Moderate Buy” by Wall Street Analysts8 Oct
  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH6 Oct
  • Head to Head Review: Tenet Healthcare (NYSE:THC) and Astrana Health (NASDAQ:ASTH)5 Oct
  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH1 Oct
  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc. - ASTH29 Sep
  • ASTH Investors Have Opportunity to Join Astrana Health, Inc. Fraud Investigation with SBS Law28 Sep

Mentions in Filings

  • n Chiang has served as our independent director since November 2024. Mr. Chiang has extensive experience in serving as a director for public and private companies. Since 2019, Mr. Chiang has served as a director of <strong>Astrana Health, Inc.</strong>, a California-based healthcare technology company. Previously, Mr. Chiang served as a director of Chijet Motor Company, Inc. (NASDAQ: CJET) from June 2023 to May 2024, and of Deep Medicine Acquisition Corp. from Oc …
    Foxx Development Holdings Inc.Astrana Health, Inc.·PRE 14A - PRELIMINARY PROXY STATEMENT·Q2 27·12 Nov
  • … ths of 2025, we recorded an approximate $147 million negative fair value adjustment (none in the 2025 third quarter). The adjustment in 2025 was made based on changes to the purchase agreement between PHP Holdings and <strong>Astrana Health</strong> and updates to PHP Holdings' working capital position. On July 1, 2025, we received $2.3 million from the sale of PHP Holdings to Astrana Health. Other Re-tenanting Activity As discussed in previous filings, we ente …
    MPT Operating Partnership, L.P.Astrana Health, Inc.·10-Q - Quarterly report Q3·Q3 26·6 Nov
  • … Mr. Chin served as a board member, Treasurer, and Secretary of Rhode Island Primary Care Physicians Corporation and as Chief Financial Officer of Akido. From 2018 to 2022, Mr. Chin served as Chief Financial Officer at <strong>Astrana Health</strong>, a publicly traded company and member of the S&P SmallCap 600. From 2011 to 2018, Mr. Chin served in finance leadership positions within Public Storage and Alexandria Real Estate Equities, both of which are publicly t …
    BIOMERICA INCAstrana Health, Inc.·DEF 14A - Definitive proxy statement·Q2 27·16 Oct
  • … Mr. Chin served as a board member, Treasurer, and Secretary of Rhode Island Primary Care Physicians Corporation and as Chief Financial Officer of Akido. From 2018 to 2022, Mr. Chin served as Chief Financial Officer at <strong>Astrana Health</strong>, a publicly traded company and member of the S&P SmallCap 600. From 2011 to 2018, Mr. Chin served in finance leadership positions within Public Storage and Alexandria Real Estate Equities, both of which are publicly t …
    BIOMERICA INCAstrana Health, Inc.·10-K/A - Annual report (amendment) FY 2026·FY26·28 Sep
  • n Chiang has served as our independent director since November 2024. Mr. Chiang has extensive experience in serving as a director for public and private companies. Since 2019, Mr. Chiang has served as a director of <strong>Astrana Health, Inc.</strong>, a California-based healthcare technology company. Previously, Mr. Chiang served as a director of Chijet Motor Company, Inc. (NASDAQ: CJET) from June 2023 to May 2024, and of Deep Medicine Acquisition Corp. from Oc …
    Foxx Development Holdings Inc.Astrana Health, Inc.·10-K - ANNUAL REPORT FY 2026·FY26·28 Sep
  • **John Chiang** has served as our director since May 2025. Mr. Chiang has served on the boards of directors of <strong>Astrana Health, Inc.</strong> (Nasdaq: ASTH) (formerly Apollo Medical Holdings, Inc.) since January 2019, Pasadena Private Lending, LLC since December 2023 (after serving on its advisory board since February 2019), ChimeTV since June 2023, GrubMarket since February 2024, Century Housing since February 2024, and Foxx Development Holdings Inc. sinc …
    OFA GroupAstrana Health, Inc.·DEF 14A - Definitive proxy statement·Q2 27·25 Sep

Key Stats

Trading

Px/Chg 1D$35.88 / +2.78%
Prev Close$38.47
% of 52Wk H73.84%
Avg Volume518.51K
Beta0.84
Mkt Cap1.78B
FD Mkt Cap1.89B

Float

Shrs Out/Float49.58M / 39.24M
Short Float0.07%
Days to Cover3.07
Stock Repurchased$2.91M

Current Valuation

EV2.14B
EV/EBITDA13.16
EV/Sales0.61
P/B2.22
P/S0.50
FCF Yield3.60%
ROE1.80%
ROA0.61%
Current Ratio1.35

Estimates

P/E58.85
Est P/E0.00
Est EPS0.29
Est PEG0.00

Valuation

Metric5Yr AvgMar '23Mar '24May '25May '26Oct '26
PRICE-BASED RATIOS
Price / Earnings104.9635.6232.3036.96296.09123.85
Price / Sales1.471.411.410.781.871.85
Price / Book Value2.582.973.192.242.282.23
Price / Free Cash Flow-31.5927.1949.4036.10-298.5327.91
ENTERPRISE VALUE METRICS
Enterprise Value1,857.31,566.41,784.91,579.52,204.02,151.9
Enterprise Value / Sales1.601.371.290.782.322.23
Enterprise Value / EBITDA26.9413.9814.4311.1453.2041.96
Enterprise Value / EBIT39.0916.5716.8513.8788.0760.09

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '21Dec '22Dec '23Dec '24Dec '25
INCOME STATEMENT
Revenue42.4%773.91,144.21,386.72,034.53,181.8
Gross Income13.6%177.8199.5215.0271.4295.8
EBITDA7.7%100.7112.1123.7141.8135.3
EBIT1.9%83.194.5105.9113.989.5
Net Income-24.4%68.945.260.743.122.5
EPS (Diluted)-25.8%1.520.991.290.900.46
BALANCE SHEET
Cash & ST Inv10.6%286.5293.6296.3290.8429.5
Total Assets26.5%867.4966.2933.41,354.92,218.7
Total Liabilities46.9%356.7407.7522.6840.71,660.3
Total Shareholder Equity14.8%448.2542.6614.2712.7779.3
CASH FLOW
Net Operating Cash Flow13%70.382.168.252.2114.6
Cap Ex-14.8%-19.2-22.9-28.5-8.0-10.1
Free Cash Flow19.6%51.159.239.744.2104.5

Enterprise Value Bridge

Millions USD12 Nov '26
Price (As of 12 Nov '26)31.41
Basic Shares49.58
Market Cap1,557.4
Diluted Shares49.92
Fully Diluted Shares Outstanding49.92
Fully Diluted Market Cap1,567.9
+Consolidated Debt977.4
−In-the-Money Convertible Debt—
+Capital Leases52.0
+Operating Leases—
−Cash & Equivalents-396.2
−Short-term Investments-
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest-225.1
+Pension Liabilities—
Enterprise Value1,913.5

Segment data

Revenue

by Products and services

  • Health Care Capitation Revenue92%
  • Health Care, Patient Service4%
  • Health Care, Other3%
  • Management Service1%
  • Product And Service, Other1%

Related companies

Cgi Inc

GIB US

Gartner Inc

IT US

Booz Allen Hamilton Holding Corp

BAH US

Fti Consulting, Inc

FCN US

Exponent Inc

EXPO US

Huron Consulting Group Inc.

HURN US

ICF International, Inc.

ICFI US

Montrose Environmental Group, Inc.

MEG US

Evolent Health, Inc.

EVH US

Rmr Group Inc.

RMR US

Hackett Group, Inc.

HCKT US

Public Policy Holding Company, Inc.

PPHC US

Astrana Health, Inc. — Company Profile

Astrana Health, Inc., which rebranded from Apollo Medical Holdings, Inc. in February 2024, is a healthcare management firm based in Alhambra, California, founded in 1985. This company delivers medical services throughout the United States, operating with a physician-centered approach powered by advanced technology. Its operations are structured across three distinct divisions: Care Partners, Care Delivery, and Care Enablement. Astrana Health utilizes its exclusive platform for population health management and healthcare delivery to implement an integrated, value-based care model. This strategic approach empowers the healthcare providers within its network to offer high-quality care to their patients. The organization provides extensive care coordination services to a broad spectrum of stakeholders, including patients, their families, primary care physicians, specialists, acute care hospitals, other inpatient facilities, physician groups, and health plans. Its robust physician network encompasses primary care doctors, specialized practitioners, advanced practice providers (extenders), and hospital-based physicians. Astrana Health serves a diverse patient base, primarily those with insurance coverage—such as private plans, Medicare, Medicaid, and HMOs—but also extends care to uninsured individuals.

Sector
Communication Services
Industry
Media
Exchange
UQ
CEO
Brandon K. Sim
Headquarters
Alhambra, CA, US
IPO Date
Mar 11, 2009
Employees
3,000
Website
www.astranahealth.com

Key Metrics

Price
$35.88
Market Cap
$1.78B
Revenue (TTM)
$965.10M
Net Income (TTM)
$14.44M
EPS (TTM)
0.30
P/E (TTM)
58.85
P/B (TTM)
2.22
Dividend Yield
0.00%
ROE (TTM)
1.80%
ROA (TTM)
0.61%
Operating Margin
2.96%
Beta
0.84

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

Astrana Health, Inc., which rebranded from Apollo Medical Holdings, Inc. in February 2024, is a healthcare management firm based in Alhambra, California, founded in 1985. This company delivers medical services throughout the United States, operating with a physician-centered approach powered by advanced technology. Its operations are structured across three distinct divisions: Care Partners, Care Delivery, and Care Enablement. Astrana Health utilizes its exclusive platform for population health management and healthcare delivery to implement an integrated, value-based care model. This strategic approach empowers the healthcare providers within its network to offer high-quality care to their patients. The organization provides extensive care coordination services to a broad spectrum of stakeholders, including patients, their families, primary care physicians, specialists, acute care hospitals, other inpatient facilities, physician groups, and health plans. Its robust physician network encompasses primary care doctors, specialized practitioners, advanced practice providers (extenders), and hospital-based physicians. Astrana Health serves a diverse patient base, primarily those with insurance coverage—such as private plans, Medicare, Medicaid, and HMOs—but also extends care to uninsured individuals.

Website
www.astranahealth.com
Location
Alhambra, CA, US
Phone626 282 0288
Employees3,000
CEOBrandon K. Sim
Sector
Communication Services
Industry
Media
IPO DateMar 11, 2009

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.
How it makes money
A short diagram of the business model.

Latest Documents

SEC Filings(1K)

Expand
  • 10-QQ3ended 30 Sept 20266 Nov
  • 8-KResults of Operations and Financial Condition5 Nov
  • SC 13G/AAstrana Health, Inc.30 Oct
  • Form 4Vong John13 Oct
  • Form 4Sim Brandon8 Oct
  • Form 4Lam Thomas S.8 Oct
  • Form 4Basho Chandan6 Oct
  • 8-KRegulation FD Disclosure23 Sep
  • 8-K<ITEMS>1.0523 Sep
  • Form 4Vong John17 Sep
  • 8-KRegulation FD Disclosure15 Sep
  • Form 4Sim Brandon9 Sep
  • Form 4Basho Chandan8 Sep
  • Form 4Kitayama Mitchell W1 Sep
  • Form 4Schmidt David18 Aug
  • Form 3Vong John11 Aug
  • Form 4Sobotka Glenn11 Aug
  • 10-QQ2ended 30 Jun 202610 Aug
  • 8-KResults of Operations and Financial Condition6 Aug
  • SC 13GAstrana Health, Inc.31 Jul

News

  • Foothill Regional Medical Center Recognized Among Healthgrades' 2027 America's 100 Best Hospitals for Orthopedic Surgery and Joint Replacement10 Nov
  • Astrana Health, Inc. (ASTH) Q3 2026 Earnings Call Transcript6 Nov
  • Astrana Health Q3 Earnings Call Highlights5 Nov
  • Astrana Health, Inc. (ASTH) Q3 Earnings Lag Estimates5 Nov
  • Astrana Health, Inc. Reports Third Quarter 2026 Results5 Nov
  • Diamond Hill Small Cap Fund Q3 2026 Portfolio Activity28 Oct
  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH22 Oct
  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH20 Oct
  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH15 Oct
  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH13 Oct
  • Is It Too Late to Buy Astrana Health Inc (ASTH) After 4.7% Rally? GF Value Says Undervalued9 Oct
  • Astrana Health, Inc. Schedules 2026 Third Quarter Financial Results Release and Conference Call9 Oct
  • Why Astrana Health, Inc. (ASTH) is Poised to Beat Earnings Estimates Again9 Oct
  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH8 Oct
  • Astrana Health, Inc. (NASDAQ:ASTH) Stock Rated “Moderate Buy” by Wall Street Analysts8 Oct
  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH6 Oct
  • Head to Head Review: Tenet Healthcare (NYSE:THC) and Astrana Health (NASDAQ:ASTH)5 Oct
  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH1 Oct
  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc. - ASTH29 Sep
  • ASTH Investors Have Opportunity to Join Astrana Health, Inc. Fraud Investigation with SBS Law28 Sep

Mentions in Filings

  • n Chiang has served as our independent director since November 2024. Mr. Chiang has extensive experience in serving as a director for public and private companies. Since 2019, Mr. Chiang has served as a director of <strong>Astrana Health, Inc.</strong>, a California-based healthcare technology company. Previously, Mr. Chiang served as a director of Chijet Motor Company, Inc. (NASDAQ: CJET) from June 2023 to May 2024, and of Deep Medicine Acquisition Corp. from Oc …
    Foxx Development Holdings Inc.Astrana Health, Inc.·PRE 14A - PRELIMINARY PROXY STATEMENT·Q2 27·12 Nov
  • … ths of 2025, we recorded an approximate $147 million negative fair value adjustment (none in the 2025 third quarter). The adjustment in 2025 was made based on changes to the purchase agreement between PHP Holdings and <strong>Astrana Health</strong> and updates to PHP Holdings' working capital position. On July 1, 2025, we received $2.3 million from the sale of PHP Holdings to Astrana Health. Other Re-tenanting Activity As discussed in previous filings, we ente …
    MPT Operating Partnership, L.P.Astrana Health, Inc.·10-Q - Quarterly report Q3·Q3 26·6 Nov
  • … Mr. Chin served as a board member, Treasurer, and Secretary of Rhode Island Primary Care Physicians Corporation and as Chief Financial Officer of Akido. From 2018 to 2022, Mr. Chin served as Chief Financial Officer at <strong>Astrana Health</strong>, a publicly traded company and member of the S&P SmallCap 600. From 2011 to 2018, Mr. Chin served in finance leadership positions within Public Storage and Alexandria Real Estate Equities, both of which are publicly t …
    BIOMERICA INCAstrana Health, Inc.·DEF 14A - Definitive proxy statement·Q2 27·16 Oct
  • … Mr. Chin served as a board member, Treasurer, and Secretary of Rhode Island Primary Care Physicians Corporation and as Chief Financial Officer of Akido. From 2018 to 2022, Mr. Chin served as Chief Financial Officer at <strong>Astrana Health</strong>, a publicly traded company and member of the S&P SmallCap 600. From 2011 to 2018, Mr. Chin served in finance leadership positions within Public Storage and Alexandria Real Estate Equities, both of which are publicly t …
    BIOMERICA INCAstrana Health, Inc.·10-K/A - Annual report (amendment) FY 2026·FY26·28 Sep
  • n Chiang has served as our independent director since November 2024. Mr. Chiang has extensive experience in serving as a director for public and private companies. Since 2019, Mr. Chiang has served as a director of <strong>Astrana Health, Inc.</strong>, a California-based healthcare technology company. Previously, Mr. Chiang served as a director of Chijet Motor Company, Inc. (NASDAQ: CJET) from June 2023 to May 2024, and of Deep Medicine Acquisition Corp. from Oc …
    Foxx Development Holdings Inc.Astrana Health, Inc.·10-K - ANNUAL REPORT FY 2026·FY26·28 Sep
  • **John Chiang** has served as our director since May 2025. Mr. Chiang has served on the boards of directors of <strong>Astrana Health, Inc.</strong> (Nasdaq: ASTH) (formerly Apollo Medical Holdings, Inc.) since January 2019, Pasadena Private Lending, LLC since December 2023 (after serving on its advisory board since February 2019), ChimeTV since June 2023, GrubMarket since February 2024, Century Housing since February 2024, and Foxx Development Holdings Inc. sinc …
    OFA GroupAstrana Health, Inc.·DEF 14A - Definitive proxy statement·Q2 27·25 Sep

Key Stats

Trading

Px/Chg 1D$35.88 / +2.78%
Prev Close$38.47
% of 52Wk H73.84%
Avg Volume518.51K
Beta0.84
Mkt Cap1.78B
FD Mkt Cap1.89B

Float

Shrs Out/Float49.58M / 39.24M
Short Float0.07%
Days to Cover3.07
Stock Repurchased$2.91M

Current Valuation

EV2.14B
EV/EBITDA13.16
EV/Sales0.61
P/B2.22
P/S0.50
FCF Yield3.60%
ROE1.80%
ROA0.61%
Current Ratio1.35

Estimates

P/E58.85
Est P/E0.00
Est EPS0.29
Est PEG0.00

Valuation

Metric5Yr AvgMar '23Mar '24May '25May '26Oct '26
PRICE-BASED RATIOS
Price / Earnings104.9635.6232.3036.96296.09123.85
Price / Sales1.471.411.410.781.871.85
Price / Book Value2.582.973.192.242.282.23
Price / Free Cash Flow-31.5927.1949.4036.10-298.5327.91
ENTERPRISE VALUE METRICS
Enterprise Value1,857.31,566.41,784.91,579.52,204.02,151.9
Enterprise Value / Sales1.601.371.290.782.322.23
Enterprise Value / EBITDA26.9413.9814.4311.1453.2041.96
Enterprise Value / EBIT39.0916.5716.8513.8788.0760.09

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '21Dec '22Dec '23Dec '24Dec '25
INCOME STATEMENT
Revenue42.4%773.91,144.21,386.72,034.53,181.8
Gross Income13.6%177.8199.5215.0271.4295.8
EBITDA7.7%100.7112.1123.7141.8135.3
EBIT1.9%83.194.5105.9113.989.5
Net Income-24.4%68.945.260.743.122.5
EPS (Diluted)-25.8%1.520.991.290.900.46
BALANCE SHEET
Cash & ST Inv10.6%286.5293.6296.3290.8429.5
Total Assets26.5%867.4966.2933.41,354.92,218.7
Total Liabilities46.9%356.7407.7522.6840.71,660.3
Total Shareholder Equity14.8%448.2542.6614.2712.7779.3
CASH FLOW
Net Operating Cash Flow13%70.382.168.252.2114.6
Cap Ex-14.8%-19.2-22.9-28.5-8.0-10.1
Free Cash Flow19.6%51.159.239.744.2104.5

Enterprise Value Bridge

Millions USD12 Nov '26
Price (As of 12 Nov '26)31.41
Basic Shares49.58
Market Cap1,557.4
Diluted Shares49.92
Fully Diluted Shares Outstanding49.92
Fully Diluted Market Cap1,567.9
+Consolidated Debt977.4
−In-the-Money Convertible Debt—
+Capital Leases52.0
+Operating Leases—
−Cash & Equivalents-396.2
−Short-term Investments-
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest-225.1
+Pension Liabilities—
Enterprise Value1,913.5

Segment data

Revenue

by Products and services

  • Health Care Capitation Revenue92%
  • Health Care, Patient Service4%
  • Health Care, Other3%
  • Management Service1%
  • Product And Service, Other1%

Related companies

Cgi Inc

GIB US

Gartner Inc

IT US

Booz Allen Hamilton Holding Corp

BAH US

Fti Consulting, Inc

FCN US

Exponent Inc

EXPO US

Huron Consulting Group Inc.

HURN US

ICF International, Inc.

ICFI US

Montrose Environmental Group, Inc.

MEG US

Evolent Health, Inc.

EVH US

Rmr Group Inc.

RMR US

Hackett Group, Inc.

HCKT US

Public Policy Holding Company, Inc.

PPHC US